4
Changes in Ownership
Enliven Therapeutics, Inc. Filed Acc 0001415889-25-011121
PRESIDENT AND CEO sold 5,000 shares at $16.42 ($82,096)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kintz Samuel · PRESIDENT AND CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-17 | Sale : show line 1 in the form 10b5-1 | −5,000 | $16.42 | $82,096 | 985,392 | I |
| Open-market sales · 5,000 sh · avg $16.42 · $82,096 | ||||||
Loading xslF345X05/form4-04212025_090428.xml…